Literature DB >> 12695280

Postmenopausal hormone therapy: a reversal of fortune.

Karin B Michels, JoAnn E Manson.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12695280     DOI: 10.1161/01.CIR.0000064601.65196.DF

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  7 in total

1.  [Cardiovascular prevention and rehabilitation].

Authors:  C von Schacky
Journal:  Internist (Berl)       Date:  2003-12-20       Impact factor: 0.743

Review 2.  Synthesising licensing data to assess drug safety.

Authors:  Klim McPherson; Elina Hemminki
Journal:  BMJ       Date:  2004-02-28

3.  Where are we now with hormone replacement therapy?

Authors:  Klim McPherson
Journal:  BMJ       Date:  2004-02-14

4.  [Role of hormone-replacement therapy for prevention of coronary artery disease in women].

Authors:  C Gohlke-Bärwolf; C von Schacky
Journal:  Z Kardiol       Date:  2005

5.  Assessing potentially time-dependent treatment effect from clinical trials and observational studies for survival data, with applications to the Women's Health Initiative combined hormone therapy trial.

Authors:  Song Yang; Ross L Prentice
Journal:  Stat Med       Date:  2015-02-17       Impact factor: 2.373

6.  Reproductive factors and risk of primary brain tumors in women.

Authors:  Gabriella M Anic; Melissa H Madden; L Burton Nabors; Jeffrey J Olson; Renato V LaRocca; Zachary J Thompson; Shitaldas J Pamnani; Peter A Forsyth; Reid C Thompson; Kathleen M Egan
Journal:  J Neurooncol       Date:  2014-04-04       Impact factor: 4.130

7.  An analytic framework for aligning observational and randomized trial data: Application to postmenopausal hormone therapy and coronary heart disease.

Authors:  Sengwee Toh; Joann E Manson
Journal:  Stat Biosci       Date:  2013-11-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.